Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for RedHill Biopharma (RDHL) over the last 16 years, with Dec 2024 value amounting to $8.4 million.

  • RedHill Biopharma's Interest & Investment Income rose 326.90% to $7.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $40.6 million, marking a year-over-year increase of 2284.89%. This contributed to the annual value of $8.4 million for FY2024, which is 59.78% down from last year.
  • According to the latest figures from FY2024, RedHill Biopharma's Interest & Investment Income is $8.4 million, which was down 59.78% from $20.9 million recorded in FY2023.
  • RedHill Biopharma's 5-year Interest & Investment Income high stood at $20.9 million for FY2023, and its period low was $51,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $14.3 million, with a median of $13.6 million in 2022.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 81.11% in 2021, then spiked by 26,492.16% in 2022.
  • Over the past 5 years, RedHill Biopharma's Interest & Investment Income (Yearly) stood at $270,000 in 2020, then plummeted by 81.11% to $51,000 in 2021, then soared by 26,492.16% to $13.6 million in 2022, then soared by 54.03% to $20.9 million in 2023, then plummeted by 59.78% to $8.4 million in 2024.